Zhou, Xin <br/><br/>
Evaluation of neutrophil-to-lymphocyte ratio in newly diagnosed patients receiving borte- zomib-based therapy for multiple myeloma.  [electronic resource] 

 -  Cancer biomarkers : section A of Disease markers  2018 
 - 43-48 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1875-8592 
<br/><br/><label>Standard No.: </label>10.3233/CBM-170795  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Bortezomib--therapeutic use<br/>Female<br/>Humans<br/>Lymphocytes--drug effects<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--blood<br/>Neutrophils--drug effects<br/>Prognosis<br/>Retrospective Studies